Thomas Glanzmann
Partner
Thomas has 35 years of experience in healthcare with medical devices, biologics, and diagnostics. He has worked with global public companies, private equity, startups, and nonprofits.
He was CEO of Gambro and led the company in the largest private equity transaction in Europe at the time. Previously, Thomas was CEO of HemoCue, which he led to a successful exit. Prior, he was Senior Vice President of Baxter Healthcare / Baxter International and President of Baxter Bioscience. He has also been CEO of Immuno International, a leading global plasma and vaccines company. He was a Managing Director at the World Economic Forum, Davos and for 10 years also served as Healthcare Advisor to Madison Dearborn+Partners, a Chicago based Private Equity firm.
Currently, Thomas is Vice Chairman of Grifols SA and the Chairman of the Grifols Sustainability Committee. He is also a Board member of Alcon Inc., where he chairs the Innovation Committee and is a member of the Compensation and Governance Committees.
Thomas is a graduate of Dartmouth College and holds an MBA from IMD in Switzerland. He has a Board of Directors Certification from the UCLA Anderson School of Management. Currently he commutes between the US, Switzerland, and Sweden.